Donna Wamsley, director of research and analytics, SōRSE Technology, Seattle, also pointed to the importance of ensuring the safety of ingredients.
“All product developers care about consumer safety, and because of that, they’re looking for an emulsion featuring safe ingredients,” she says. “This is why we have a robust quality assurance program that looks into providing solutions to various product development concerns as well as managing third-party testing.”
Beyond quality, manufacturers are seeking customizable options that meet their concerns and those of the end consumers, says Mark Elfenbein, chief revenue officer, Socati Corp, Austin, TX. “Typically product developers are looking for two things: the ability to customize the minor cannabinoid ratios such that they can ensure a specific quantity of any specific cannabinoid for purposes of addressing a use case such as relaxation, (and) the ability to integrate other functional ingredients such as chamomile, valerian root, vitamin C, vitamin D, etc., for addressing specific use cases to the end consumer,” he says.
Over the last year, suppliers have introduced offerings of minor cannabinoids such as cannabinol (CBN), cannabigerol (CBG), and cannabichromene (CBC). Last spring, OBX partnered with Prinova to produce a collection of patented water-soluble cannabinoid ingredients, including Hydrobond CBD, Hydrobond CBG, Hydrobond CBN and Hydrobond CBC.